نتایج جستجو برای: acute gvhd

تعداد نتایج: 497927  

Journal: :Infection and immunity 2000
T Miura D Mizuki S Sasaki S Hasegawa H Sashinami A Nakane

Acute graft-versus-host disease (GVHD) is characterized by the production of high levels of T helper 1 (Th1)-type cytokines. Bone marrow transplantation from allogeneic C57BL/6 cells to CBF(1) mice produced acute GVHD. Host resistance to Th1-driven Listeria monocytogenes was enhanced, whereas host resistance to Th2-driven Staphylococcus aureus was reduced during acute GVHD. These results sugges...

Journal: :Blood 2007
Rima M Saliba Marcos de Lima Sergio Giralt Borje Andersson Issa F Khouri Chitra Hosing Shubhra Ghosh Joyce Neumann Yvonne Hsu Jorge De Jesus Muzaffar H Qazilbash Richard E Champlin Daniel R Couriel

Acute graft-versus-host disease (GVHD) is a major limiting factor in allogeneic hematopoietic stem cell transplantation (HSCT), and the timing of acute GVHD may affect patient outcomes. We evaluated the incidence, risk factors, clinical manifestations, and outcomes of hyperacute GVHD, defined as that occurring within 14 days after transplantation, among 809 consecutive HSCTs at the University o...

Journal: :Blood 1992
R A Nash M S Pepe R Storb G Longton M Pettinger C Anasetti F R Appelbaum R A Bowden H J Deeg K Doney

Previous studies of risk factors for acute graft-versus-host disease (GVHD) involved patients receiving predominantly single-agent prophylaxis. Therefore, a retrospective analysis was performed on 446 patients, from a single institution, who received transplants of marrow from HLA-identical siblings and the combination of cyclosporine (CSP) and methotrexate (MTX) to determine risk factors for a...

Journal: :Haematologica 2013
Marlies E H M Van Hoef

Recently, Bucher et al. addressed rational graft-versushost disease (GVHD) prophylaxis (December 2012 issue of this Journal). The authors addressed calcineurin inhibition and T-cell immune modulation but fully overlooked the important results obtained with rituximab that have been reported in the prevention of acute and chronic GVHD. Initial reports on the potential role of rituximab in chronic...

Journal: :Archives of dermatology 2000
Y Zhou M J Barnett J K Rivers

OBJECTIVE To determine the value of skin biopsies in the management of suspected graft-vs-host disease (GVHD) within 30 days of allogeneic bone marrow transplantation (BMT). DESIGN Retrospective study based on review of a BMT database. SETTING Leukemia/BMT ward of a tertiary care, university teaching hospital. PATIENTS One hundred and eighty-seven consecutive patients who received allogen...

2017
Daniela Weber Katrin Frauenschläger Sakhila Ghimire Katrin Peter Isabella Panzer Andreas Hiergeist Markus Weber Daniel Kutny Daniel Wolff Matthias Grube Elisabeth Huber Peter Oefner Andre Gessner Thomas Hehlgans Wolfgang Herr Ernst Holler

Intestinal microbiota disruption is associated with acute gastrointestinal (GI) Graft-versus-Host Disease (GvHD) and poor outcome after allogeneic stem cell transplantation (ASCT). Here, in a retrospective analysis of 200 patients undergoing ASCT at the Regensburg University Medical Center, we assessed the relative expression of Paneth cell antimicrobial peptides (AMPs), Human Defensins (HD) 5 ...

2013
Min-Jung Park Su-Jin Moon Sung-Hee Lee Eun-Ji Yang Jun-Ki Min Seok-Goo Cho Chul-Woo Yang Sung-Hwan Park Ho-Youn Kim Mi-La Cho

BACKGROUND In this study we examined the in vivo and in vitro effects and mechanisms of action of curcumin on the development of acute graft-versus-host disease (GVHD) using a murine model. METHODOLOGY/PRINCIPAL FINDINGS Mixed lymphocyte reactions were used to determine the in vitro effects of curcumin. Treatment with curcumin attenuated alloreactive T cell proliferation and inhibited the pro...

Journal: :Blood 2014
Javier Bolaños-Meade Brent R Logan Amin M Alousi Joseph H Antin Kate Barowski Shelly L Carter Steven C Goldstein Elizabeth O Hexner Mary M Horowitz Stephanie J Lee John E Levine Margaret L MacMillan Paul J Martin Adam M Mendizabal Ryotaro Nakamura Marcelo C Pasquini Daniel J Weisdorf Peter Westervelt Vincent T Ho

Corticosteroids are the accepted primary therapy for acute graft-versus-host disease (GVHD), but durable responses are seen in only about half of the patients. Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0802, a phase 3 multicenter randomized double-blinded trial, was designed to test whether mycophenolate mofetil (MMF) plus corticosteroids was superior to corticosteroids alon...

2014
Julia Cromvik Marianne Johnsson Krista Vaht Jan-Erik Johansson Christine Wennerås

While increased numbers of eosinophils may be detected in patients with graft-versus-host disease (GVHD) following hematopoietic stem cell transplantation, it is not known if eosinophils play a role in GVHD. The aims of this study were to determine: whether eosinophils are activated during GVHD; whether the patterns of activation are similar in acute and chronic GVHD; and the ways in which syst...

2014
Anne-Kathrin Hechinger Benjamin A. H. Smith Ryan Flynn Kathrin Hanke Cameron McDonald-Hyman Patricia A. Taylor Dietmar Pfeifer Björn Hackanson Franziska Leonhardt Gabriele Prinz Heide Dierbach Annette Schmitt-Graeff Jiri Kovarik Bruce R. Blazar Robert Zeiser

• Monoclonal antibody blockade of the common gamma chain attenuates acute and chronic GvHD. • Common gamma chain cytokines increase granzyme B levels in CD8 T cells, which is reduced upon CD132 blockade in vivo. Abstract The common gamma chain (CD132) is a subunit of the interleukin (IL) receptors for IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Because levels of several of these cytokines were sh...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید